AzTrials
AzTrials

BurnsEARLYBURNNCT02940171

Timing of Surgery And Outcome in Burn Patients ( EARLYBURN )

An observational study of Burns, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The prognostic of burn patients has improved over the last decades. Early excision of full thickness burns is thought to be one of the key factors which have led to prognostic improvement. Best timing for burn excision remain uncertain, however. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Burns
What is being tested?
Early Excision of full thickness burn and Late Excision of full thickness burn
Type of treatment
Surgery or procedure
How many people
470 participants
Where
1 siteFrance
Study dates
25 Dec 2016to 11 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with extensive skin burns, defined as greater than 20% of the total body surface

Who may be able to join

  • Age >18 years
  • Admission to a burn unit within 72 hours from a burn injury
  • Total burned surface area (TBSA)>20%(2nd degree or 3rd degree) for any type of burn
  • Patient covered by the social security
  • Non-opposition to participate to the study and to the constitution of the biological collection

Who cannot join

  • Decline to participate
  • Decision not to resuscitate order before surgery
  • Pregnant or breastfeeding patiente
  • Decision to limit therapies in the first 24 hours
  • Patient not resident in France
  • Patient deprived of liberty

Trial locations and contacts

1 site in 1 country.

France1 site
  • Departement of Anesthesiology, Critical Care and Burn Unit; Saint-Louis hospital, University Paris Diderot

    Paris, 75010

Other trials in France

About this study

Official title: Impact of Timing of Surgery on Outcome of Severely Ill Burn Patients

The prognostic of burn patients has improved over the last decades. Early excision of full thickness burns is thought to be one of the key factors which have led to prognostic improvement. Best timing for burn excision remain uncertain, however. In this multicenter observational study, we aim at exploring the impact of timing of surgery on outcome in severely ill burn patients using a propensity analysis.

Read the detailed description

The first aim of the study is to explore the impact of timing of the first surgery on outcome of severely ill burn patients. Because a randomization would not be feasible in this setting, we will use a propensity analysis in matching patients receiving early surgery and those receiving late surgery. Secondary aims are to evaluate the impact of the timing of surgery on morbidity (organs failure, infections, sepsis) but also to assess the diagnostic and prognostic value of plasma and urine biomarkers in severely ill burn patients

Conditions
Burns
Being tested
Early Excision of full thickness burn, Late Excision of full thickness burn
Keywords
burns, critically ill, surgery outcome, mortality
Medical subject headings
Burns, Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early Excision of full thickness burnProcedure or surgery

    Also called Early

    first excision surgery of full -thickness burn performed within 48 hours from burn injury

  • Late Excision of full thickness burnProcedure or surgery

    Also called Late

    first excision surgery of full -thickness burn performed after 48 hours from burn injury

Study groups in NCT02940171
Study groupRoleWhat they receive
Early surgeryEarly Excision of full thickness burn First excision surgery of full -thickness burn performed within 48 hours from burn injury
Receives: Procedure: Early Excision of full thickness burn
Late surgeryLate Excision of full thickness burn First excision surgery of full -thickness burn performed after 48 hours from burn injury
Receives: Procedure: Late Excision of full thickness burn

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. mortality

    Measured: 90 days

Secondary outcomes (8)
  1. Organ failure

    Measured: 28 and 60 days

  2. Recovery from acute kidney

    Measured: Until 28 and 60 days from burn injury

  3. Median Sequential Organ Failure Assessment score (SOFA score) during first 28 days

    Median Sequential Organ Failure Assessment score (SOFA score) during first 28

    Measured: First 28 days

  4. Nosocomial infections (numbers) during first 60 days

    Nosocomial infections (numbers) during first 60 days

    Measured: First 60 days

  5. Nosocomial sepsis during first 60 days

    Nosocomial sepsis during first 60 days

    Measured: First 60 days

  6. Length of stay in the ICU

    Length of stay in the ICU

    Measured: One year

  7. analog scale of quality of life

    Functional sequel at one year, the patient will assesassess his overall quality of life since his accident Scale 1 to 10, with 1: poor, 10: good

    Measured: One year

  8. One year mortality

    One year mortality

    Measured: One year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Oct 2016 (estimated)
  2. Study start25 Dec 2016
  3. Primary completion11 Dec 2023
  4. Study completion11 Dec 2023

Why it stopped: Enrollment was stopped early due to heavy workload at burn care centers and the impact of the COVID-19 pandemic.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
470 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02940171
Sponsor's protocol ID
NI 14029
Acronym
EARLYBURN
Status last verified
May 2026
First submitted
17 Oct 2016
Last updated
14 May 2026
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Burns, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Enrollment was stopped early due to heavy workload at burn care centers and the impact of the COVID-19 pandemic.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

mortality (time frame: 90 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in